| 4.60 Data as of 1:35pm ET |  -0.145 / -3.06%Today’s Change | 4.41 Today|||52-Week Range 11.44 | -29.31% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $413.0M |
Rigel Pharmaceuticals, Inc. 1180 Veterans Boulevard South San Francisco California 94080-1985 |
| Mutual fund holders | 48.57% |
| Other institutional | 42.90% |
| Individual stakeholders | 10.87% |
| James M. Gower, MBA | Chairman & Chief Executive Officer |
| Raul R. Rodriguez, MBA | President & Chief Operating Officer |
| Ryan D. Maynard, CPA | CFO, Executive VP & Head-Investor Relations |
| Elliott B. Grossbard, MD | Chief Medical Officer & Executive Vice President |
| Donald G. Payan, MD | Director, EVP, President-Discovery & Research |
.
